1 | consideration | 3,355 |
2 | scrutiny | 270 |
3 | questioning | 246 |
4 | tuning | 204 |
5 | widening | 195 |
6 | broadening | 137 |
7 | credit | 117 |
8 | weakening | 116 |
9 | subdivision | 67 |
10 | reconsideration | 62 |
11 | skewing | 31 |
12 | rethinking | 28 |
13 | grounding | 18 |
14 | mastering | 16 |
15 | asa-dhe | 9 |
16 | maneuvering | 9 |
17 | 'qi | 8 |
18 | cognizance | 8 |
19 | reaccess | 8 |
20 | waiving | 7 |
21 | 6-dmai | 6 |
22 | butyryl-coa | 5 |
23 | carefulness | 5 |
24 | chemotherapie | 5 |
25 | stereocontrol | 5 |
26 | acst-2 | 4 |
27 | briquettes | 4 |
28 | brv-oh | 4 |
29 | re-review | 4 |
30 | sdp1 | 4 |
31 | superhydrophilicity | 4 |
32 | thinker | 4 |
33 | 'beliefs | 3 |
34 | 24-hydroxycholesterol | 3 |
35 | 6-dmat | 3 |
36 | calotte | 3 |
37 | hand-occlusion | 3 |
38 | limelight | 3 |
39 | overhaul | 3 |
40 | 1,2-distearoyl-sn-glycero-3-phosphocholine | 2 |
41 | 3,4-dihydroxy-pa | 2 |
42 | 3-oxohexobarbital | 2 |
43 | anesthetization | 2 |
44 | apomixis | 2 |
45 | c-germanyne | 2 |
46 | cd-mof-2 | 2 |
47 | chads2-score | 2 |
48 | challenge-tests | 2 |
49 | consoling | 2 |
50 | e-cuidate | 2 |
51 | emg-guidance | 2 |
52 | emulsomes | 2 |
53 | forfeiting | 2 |
54 | palaeopathology | 2 |
55 | pires2-lif-egfp | 2 |
56 | resection-suspension-interposition-arthroplasty | 2 |
57 | yino3 | 2 |
58 | 'men | 1 |
59 | 'scrub | 1 |
60 | 03-01 | 1 |
61 | 1,3-diarylpropenes | 1 |
62 | 146h | 1 |
63 | 2,3-dibromobenzothiophene | 1 |
64 | 2-aryl-3-iodopyrrolidines | 1 |
65 | 200-folds | 1 |
66 | 41,548 | 1 |
67 | 6,7-position | 1 |
68 | account.it | 1 |
69 | block-printing | 1 |
70 | cochaperonin | 1 |
71 | commonalities/variability | 1 |
72 | convex-concave | 1 |
73 | cosampling | 1 |
74 | cyclopalladation | 1 |
75 | dapaglifozin | 1 |
76 | disrepute | 1 |
77 | dose-effect/toxicity | 1 |
78 | drugs.aaas | 1 |
79 | erbb2/her2 | 1 |
80 | exasperated | 1 |
81 | fishponds | 1 |
82 | high-operating | 1 |
83 | hydroxyderivatives | 1 |
84 | inanalysis | 1 |
85 | institutions/strata | 1 |
86 | knowlegde | 1 |
87 | nm-only | 1 |
88 | patients'comorbidity | 1 |
89 | photocoagulation.care | 1 |
90 | radiograhy | 1 |
91 | redeployment | 1 |
92 | retuning | 1 |
93 | ropivacaine/bupivacaine | 1 |
94 | self-ensnarement | 1 |
95 | stress-defense | 1 |
96 | tail-biopsy | 1 |
97 | vasoarchitecture | 1 |
98 | western-based | 1 |
99 | witnesses.on | 1 |
100 | λ=0 | 1 |
1 | 'beliefs | 3 |
2 | 'men | 1 |
3 | 'qi | 8 |
4 | 'scrub | 1 |
5 | 03-01 | 1 |
6 | 1,2-distearoyl-sn-glycero-3-phosphocholine | 2 |
7 | 1,3-diarylpropenes | 1 |
8 | 146h | 1 |
9 | 2,3-dibromobenzothiophene | 1 |
10 | 2-aryl-3-iodopyrrolidines | 1 |
11 | 200-folds | 1 |
12 | 24-hydroxycholesterol | 3 |
13 | 3,4-dihydroxy-pa | 2 |
14 | 3-oxohexobarbital | 2 |
15 | 41,548 | 1 |
16 | 6,7-position | 1 |
17 | 6-dmai | 6 |
18 | 6-dmat | 3 |
19 | account.it | 1 |
20 | acst-2 | 4 |
21 | anesthetization | 2 |
22 | apomixis | 2 |
23 | asa-dhe | 9 |
24 | block-printing | 1 |
25 | briquettes | 4 |
26 | broadening | 137 |
27 | brv-oh | 4 |
28 | butyryl-coa | 5 |
29 | c-germanyne | 2 |
30 | calotte | 3 |
31 | carefulness | 5 |
32 | cd-mof-2 | 2 |
33 | chads2-score | 2 |
34 | challenge-tests | 2 |
35 | chemotherapie | 5 |
36 | cochaperonin | 1 |
37 | cognizance | 8 |
38 | commonalities/variability | 1 |
39 | consideration | 3,355 |
40 | consoling | 2 |
41 | convex-concave | 1 |
42 | cosampling | 1 |
43 | credit | 117 |
44 | cyclopalladation | 1 |
45 | dapaglifozin | 1 |
46 | disrepute | 1 |
47 | dose-effect/toxicity | 1 |
48 | drugs.aaas | 1 |
49 | e-cuidate | 2 |
50 | emg-guidance | 2 |
51 | emulsomes | 2 |
52 | erbb2/her2 | 1 |
53 | exasperated | 1 |
54 | fishponds | 1 |
55 | forfeiting | 2 |
56 | grounding | 18 |
57 | hand-occlusion | 3 |
58 | high-operating | 1 |
59 | hydroxyderivatives | 1 |
60 | inanalysis | 1 |
61 | institutions/strata | 1 |
62 | knowlegde | 1 |
63 | limelight | 3 |
64 | maneuvering | 9 |
65 | mastering | 16 |
66 | nm-only | 1 |
67 | overhaul | 3 |
68 | palaeopathology | 2 |
69 | patients'comorbidity | 1 |
70 | photocoagulation.care | 1 |
71 | pires2-lif-egfp | 2 |
72 | questioning | 246 |
73 | radiograhy | 1 |
74 | re-review | 4 |
75 | reaccess | 8 |
76 | reconsideration | 62 |
77 | redeployment | 1 |
78 | resection-suspension-interposition-arthroplasty | 2 |
79 | rethinking | 28 |
80 | retuning | 1 |
81 | ropivacaine/bupivacaine | 1 |
82 | scrutiny | 270 |
83 | sdp1 | 4 |
84 | self-ensnarement | 1 |
85 | skewing | 31 |
86 | stereocontrol | 5 |
87 | stress-defense | 1 |
88 | subdivision | 67 |
89 | superhydrophilicity | 4 |
90 | tail-biopsy | 1 |
91 | thinker | 4 |
92 | tuning | 204 |
93 | vasoarchitecture | 1 |
94 | waiving | 7 |
95 | weakening | 116 |
96 | western-based | 1 |
97 | widening | 195 |
98 | witnesses.on | 1 |
99 | yino3 | 2 |
100 | λ=0 | 1 |
1 | λ=0 | 1 |
2 | 03-01 | 1 |
3 | sdp1 | 4 |
4 | cd-mof-2 | 2 |
5 | acst-2 | 4 |
6 | erbb2/her2 | 1 |
7 | yino3 | 2 |
8 | 41,548 | 1 |
9 | butyryl-coa | 5 |
10 | 3,4-dihydroxy-pa | 2 |
11 | institutions/strata | 1 |
12 | 'scrub | 1 |
13 | western-based | 1 |
14 | exasperated | 1 |
15 | emg-guidance | 2 |
16 | cognizance | 8 |
17 | knowlegde | 1 |
18 | asa-dhe | 9 |
19 | chemotherapie | 5 |
20 | 2,3-dibromobenzothiophene | 1 |
21 | ropivacaine/bupivacaine | 1 |
22 | 1,2-distearoyl-sn-glycero-3-phosphocholine | 2 |
23 | c-germanyne | 2 |
24 | photocoagulation.care | 1 |
25 | chads2-score | 2 |
26 | vasoarchitecture | 1 |
27 | stress-defense | 1 |
28 | e-cuidate | 2 |
29 | calotte | 3 |
30 | disrepute | 1 |
31 | convex-concave | 1 |
32 | grounding | 18 |
33 | rethinking | 28 |
34 | consoling | 2 |
35 | cosampling | 1 |
36 | broadening | 137 |
37 | widening | 195 |
38 | weakening | 116 |
39 | questioning | 246 |
40 | tuning | 204 |
41 | retuning | 1 |
42 | mastering | 16 |
43 | maneuvering | 9 |
44 | high-operating | 1 |
45 | forfeiting | 2 |
46 | block-printing | 1 |
47 | waiving | 7 |
48 | skewing | 31 |
49 | 146h | 1 |
50 | brv-oh | 4 |
51 | 6-dmai | 6 |
52 | 'qi | 8 |
53 | 3-oxohexobarbital | 2 |
54 | 24-hydroxycholesterol | 3 |
55 | stereocontrol | 5 |
56 | overhaul | 3 |
57 | 'men | 1 |
58 | cochaperonin | 1 |
59 | dapaglifozin | 1 |
60 | witnesses.on | 1 |
61 | subdivision | 67 |
62 | hand-occlusion | 3 |
63 | cyclopalladation | 1 |
64 | consideration | 3,355 |
65 | reconsideration | 62 |
66 | anesthetization | 2 |
67 | 6,7-position | 1 |
68 | pires2-lif-egfp | 2 |
69 | thinker | 4 |
70 | drugs.aaas | 1 |
71 | 200-folds | 1 |
72 | fishponds | 1 |
73 | emulsomes | 2 |
74 | 1,3-diarylpropenes | 1 |
75 | 2-aryl-3-iodopyrrolidines | 1 |
76 | briquettes | 4 |
77 | hydroxyderivatives | 1 |
78 | 'beliefs | 3 |
79 | inanalysis | 1 |
80 | apomixis | 2 |
81 | reaccess | 8 |
82 | carefulness | 5 |
83 | challenge-tests | 2 |
84 | 6-dmat | 3 |
85 | limelight | 3 |
86 | account.it | 1 |
87 | credit | 117 |
88 | self-ensnarement | 1 |
89 | redeployment | 1 |
90 | re-review | 4 |
91 | palaeopathology | 2 |
92 | radiograhy | 1 |
93 | nm-only | 1 |
94 | scrutiny | 270 |
95 | tail-biopsy | 1 |
96 | superhydrophilicity | 4 |
97 | dose-effect/toxicity | 1 |
98 | patients'comorbidity | 1 |
99 | commonalities/variability | 1 |
100 | resection-suspension-interposition-arthroplasty | 2 |